Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4561393
Max Phase: Preclinical
Molecular Formula: C36H36Cl2F3N7O7S
Molecular Weight: 724.67
Molecule Type: Unknown
Associated Items:
ID: ALA4561393
Max Phase: Preclinical
Molecular Formula: C36H36Cl2F3N7O7S
Molecular Weight: 724.67
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C)C/C=C/C(=O)Nc1cccc(S(=O)(=O)N2CCC(NC(=O)c3n[nH]c(-c4ccccc4)c3NC(=O)c3c(Cl)cccc3Cl)CC2)c1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C34H35Cl2N7O5S.C2HF3O2/c1-42(2)18-8-15-28(44)37-24-11-6-12-25(21-24)49(47,48)43-19-16-23(17-20-43)38-34(46)32-31(30(40-41-32)22-9-4-3-5-10-22)39-33(45)29-26(35)13-7-14-27(29)36;3-2(4,5)1(6)7/h3-15,21,23H,16-20H2,1-2H3,(H,37,44)(H,38,46)(H,39,45)(H,40,41);(H,6,7)/b15-8+;
Standard InChI Key: YYQZQBAELRXTSM-TWNLEINFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 724.67 | Molecular Weight (Monoisotopic): 723.1797 | AlogP: 5.28 | #Rotatable Bonds: 11 |
Polar Surface Area: 156.60 | Molecular Species: BASE | HBA: 7 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.68 | CX Basic pKa: 9.05 | CX LogP: 4.25 | CX LogD: 3.49 |
Aromatic Rings: 4 | Heavy Atoms: 49 | QED Weighted: 0.15 | Np Likeness Score: -1.52 |
1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS.. (2019) Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14., 29 (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024] |
Source(1):